AVLSA

Atlas Venture Life Science Advisors Portfolio holdings

AUM $662M
This Quarter Return
+23.58%
1 Year Return
+6.63%
3 Year Return
+286.7%
5 Year Return
–
10 Year Return
–
AUM
$804M
AUM Growth
+$804M
Cap. Flow
-$2.32M
Cap. Flow %
-0.29%
Top 10 Hldgs %
94.57%
Holding
16
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

1
VRDN icon
Viridian Therapeutics
VRDN
$2.29M
2
SPRO icon
Spero Therapeutics
SPRO
$25.7K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IRON icon
1
Disc Medicine
IRON
$2.07B
$154M 19.13%
3,461,784
– –
KYMR icon
2
Kymera Therapeutics
KYMR
$2.95B
$135M 16.76%
5,858,262
– –
DYN icon
3
Dyne Therapeutics
DYN
$1.92B
$111M 13.84%
9,885,449
– –
DAWN icon
4
Day One Biopharmaceuticals
DAWN
$769M
$90.8M 11.31%
7,608,394
– –
VIGL
5
DELISTED
Vigil Neuroscience
VIGL
$54.9M 6.83%
5,836,874
– –
THRD
6
DELISTED
Third Harmonic Bio
THRD
$52.5M 6.53%
10,907,859
– –
REPL icon
7
Replimune Group
REPL
$422M
$48.7M 6.06%
2,098,300
– –
GBIO icon
8
Generation Bio
GBIO
$40.4M
$45.5M 5.67%
8,279,484
– –
JBIO
9
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$35M 4.35%
2,039,249
– –
IMA
10
ImageneBio, Inc. Common Stock
IMA
$150M
$32.9M 4.1%
5,018,178
– –
AKRO icon
11
Akero Therapeutics
AKRO
$3.74B
$27.7M 3.45%
594,251
– –
XLO icon
12
Xilio Therapeutics
XLO
$36.3M
$7.23M 0.9%
2,759,344
– –
TECX
13
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$4.31M 0.54%
4,541,381
– –
DNTH icon
14
Dianthus Therapeutics
DNTH
$759M
$2.87M 0.36%
3,791,698
– –
SPRO icon
15
Spero Therapeutics
SPRO
$116M
$1.47M 0.18%
1,013,438
-17,722
-2% -$25.7K
VRDN icon
16
Viridian Therapeutics
VRDN
$1.5B
– –
-90,072
Closed -$2.29M